| HORIZON | TRADES | WIN RATE | INSIDER RETURN | SPY RETURN | MEAN EXCESS | MEDIAN EXCESS | T-STAT |
|---|---|---|---|---|---|---|---|
| 7d | 4 | +50.00% | -13.94% | -0.60% | -13.34% | -12.01% | — |
| 14d | 4 | +50.00% | -20.24% | -0.36% | -19.88% | -13.51% | — |
| 30d | 4 | +25.00% | +19.70% | +1.69% | +18.01% | +0.55% | — |
| 60d | 4 | +25.00% | +11.65% | +1.54% | +10.12% | -4.72% | — |
| 90d | 4 | +25.00% | +3.11% | +2.79% | +0.32% | -7.96% | — |
| 180d | 4 | +25.00% | -1.14% | +11.68% | -12.82% | -23.78% | — |
| 1y | 4 | +25.00% | +36.46% | +24.56% | +11.90% | +15.64% | — |
| 2y | 4 | +25.00% | +25.46% | +46.38% | -20.92% | -34.30% | — |
| COMPANY | TYPE | SHARES | PRICE | VALUE | HELD AFTER | TRADE DATE | FILED | DETAILS |
|---|---|---|---|---|---|---|---|---|
| VERA VERA THERAPEUTICS, INC. | SALE | 1,050,000 | $18.00 | $18.90M | 4,400,000 | Jan 10, 2024 | Jan 12, 2024 ↗ | View → |
| VTGN VISTAGEN THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 1,394,310 | — | — | 1,394,310 | Oct 4, 2023 | Oct 6, 2023 ↗ | View → |
| VTGN VISTAGEN THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 1,690,014 | — | — | 1,690,014 | Oct 4, 2023 | Oct 6, 2023 ↗ | View → |
| VTGN VISTAGEN THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 2,788,620 | — | — | 2,788,620 | Oct 4, 2023 | Oct 6, 2023 ↗ | View → |
| VTGN VISTAGEN THERAPEUTICS, INC. | PURCHASE | 775,756 | $23.15 | $17.96M | 1,575,000 | Aug 7, 2023 | Aug 9, 2023 ↗ | View → |
| VERA VERA THERAPEUTICS, INC. | PURCHASE | 448,217 | $15.17 | $6.80M | 5,450,000 | Jun 20, 2023 | Jun 22, 2023 ↗ | View → |
| ELVN ENLIVEN THERAPEUTICS, INC. | PURCHASE | 621.75 | $22.07 | $13.7K | 718,749 | Feb 23, 2023 | Feb 27, 2023 ↗ | View → |
| ELVN ENLIVEN THERAPEUTICS, INC. | PURCHASE | 729,891 | — | — | 1,448,640 | Feb 23, 2023 | Feb 27, 2023 ↗ | View → |